You are here

Article Text

Article menu
Download PDFPDF
Diagnosis
Systematic review and meta-analysis
Confirming the value of pulse oximetry screening for diagnosing critical congenital heart disease
  1. Julien I E Hoffman
  1. Department of Pediatrics, University of California, San Francisco, California, USA
  1. Correspondence to : Dr Julien I E Hoffman
    925 Tiburon Boulevard, Tiburon, CA 94920-1525, USA; julien.hoffman{at}ucsf.edu

https://doi.org/10.1136/eb-2012-100971

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Commentary on: Thangaratinam S, Brown K, Zamora J, et al. Pulse oximetry screening for critical congenital heart defects in asymptomatic newborn babies: a systematic review and meta-analysis. Lancet 2012; 379:2459–64.OpenUrlCrossRefPubMedWeb of Science

    Context

    Thangaratinam and colleagues, studied the value of pulse oximetry screening of neonates for critical congenital heart disease (CCHD). CCHD is usually defined as a congenital heart disease (CHD) that requires treatment in the neonatal period to prevent death or severe morbidity; most of these neonates have ductus-dependent lesions. About 25–40% of children born with CHD have CCHD, and 10–35% of these infants leave hospital undiagnosed. Some die at home, and others return to hospital critically ill, with resulting higher operative mortality and morbidity, increased hospital costs and suboptimal outcomes.

    Pulse oximetry has been recommended to decrease these missed diagnoses, …

    View Full Text

    Footnotes

    • Competing interests None.